HVRe Influenza / RSV / SARS-CoV-2 Respiratory Panel Assay
On-site PCR results in 1 hour with a simple workflow
Reliably detect and differentiate between the most common respiratory pathogens this season, CE-IVD* approved for point-of-care (POC) PCR
Benefits of Fluxergy’s HVRe Influenza / RSV / SARS-CoV-2 Assay
Diagnose and treat in the same patient visit
Sensitive Real-Time-PCR testing in 75 minutes
Sample to answer workflow makes it simple for any user
Room-temperature stable for low-cost shipping and optimal storage.
Confirmatory testing in any care setting
Testimonials
“Two things about the Fluxergy system stand out, especially in the case of a viral pandemic: its accuracy using RT-PCR technology and its ability to deliver results in 1 hour at the point-of-care.”
Dr. David Smith, MD, MAS, FACP, FIDSA
Professor of Medicine, Head of the UCSD Division of Infectious Diseases And Global Public Health Member of Fluxergy’s Advisory Board
UCSD
"The Fluxergy platform’s speed, with results in one hour, and accuracy by using qPCR molecular technology are potentially strong benefits for clincal settings, especially when a quick result is needed. I also see the future value of the multimodal technology where you could potentially have different types of tests on a single point-of-care platform."
Lee B. Springer, PhD
Laboratory Director
C3 Clincal Consulting Services
“I learned of Fluxergy’s technology when I was at Boehringer Ingelheim, and I was impressed about the opportunity for this point-of-care testing platform. I am happy to be involved on Fluxergy’s advisory board where I can bring my 20+ years of animal health and R&D experience. One of the big advantages of Fluxergy’s technology is that it is very easy to use. When veterinarians see horses with high fevers, its important that they can understand quickly what is going on.”
Dr. Randolph Seidler, VMD, MBA
Former global head of R&D and business development for Boehringer Ingelheim Animal Health and Member of Fluxergy’s Advisory Board
Boehringer Ingelheim
View more assays
HVRe Influenza / RSV / SARS-CoV-2 Respiratory Panel
